Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Cancer Cell2010Vol. 18(6), pp. 553–567
Citations Over TimeTop 1% of 2010 papers
María E. Figueroa, Omar Abdel‐Wahab, Chao Lü, Patrick S. Ward, Jay Patel, Alan H. Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F. Fernández, Martin S. Tallman, Zhuoxin Sun, Kristy Wolniak, Justine Peeters, Wei Liu, Sung Choe, Valeria R. Fantin, Elisabeth Paietta, Bob Löwenberg, Jonathan D. Licht, Lucy A. Godley, Ruud Delwel, Peter J.M. Valk, Craig B. Thompson, Ross L. Levine, Ari Melnick
Related Papers
- → Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?(2010)216 cited
- → Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas(2022)32 cited
- → Molecular Investigation of Isocitrate Dehydrogenase Gene (IDH) Mutations in Gliomas: First Report of IDH2 Mutations in Indian Patients(2013)18 cited
- [IDH1/2 mutations in gliomas].(2011)
- → Epidemiological Study of Molecular and Genetic Classification in Adult Diffuse Glioma(2022)1 cited